53 completed. 53 Phase 2, 11 Phase 1, 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 53 | Completed 53 |
| Phase 1 | 11 | Completed 11 |
| Phase 3 | 8 | Completed 8 |
Follow Autism: new trials by email Literature Review of Autism trials Research Report on Autism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 12-Week Crossover Study to Assess the Efficacy, Safety and Tolerability of L1-79 in Subjects Aged 12-21 Years With Autism Spectrum Disorder L1-79 - Autism Spectrum Disorder, Autism | Phase 2 | Completed | Yamo Pharmaceuticals LLC | 58 | 2022-01-25 | 2024-07-31 |
| hCT-MSC in Children With Autism Spectrum Disorder Cord Tissue Mesenchymal Stromal Cells, Placebo Infusion - Autism, Autism Spectrum Disorder | Phase 2 | Completed | Joanne Kurtzberg, MD | 137 | 2020-10-12 | 2026-06-24 |
| Parent Telehealth Intervention for Children With Autism Responsive training with no video feedback, Responsive training with video feedback - Autism Spectrum Disorder, Autism | Phase 2 | Completed | Northwestern University | 47 | 2020-03-06 | 2022-01-10 |
| Allogenic Cord Blood Transfusion in Patients With Autism ASD CB-MNC injection., Standard therapy. - Autism Spectrum Disorder, Autism | Phase 1 / Phase 2 | Completed | State-Financed Health Facility "Samara Regional Medical Center Dinasty" | 20 | 2018-10-12 | 2020-11-19 |
| Intranasal Vasopressin Treatment in Children With Autism Vasopressin (USP) Injectable Solution [Vasostrict], Placebo - Autism, Autism Spectrum Disorder | Phase 2 / Phase 3 | Completed | Stanford University | 157 | 2018-02-20 | 2026-06-04 |
| Autism Oxytocin Brain Project 8 International Units (IU) of Oxytocin, 24IU of Oxytocin, 48IU of Oxytocin - Autism, Autism Spectrum Disorder | Phase 2 | Completed | Emory University | 51 | 2017-05-10 | 2021-01-12 |
| Safety of L1-79 in Adolescent and Adult Males With Autism L1-79, Placebo - Autism | Phase 2 | Completed | Yamo Pharmaceuticals LLC | 42 | 2016-10-01 | 2024-08-21 |
| Cord Blood Infusion for Children With Autism Spectrum Disorder Cord Blood Infusion, Placebo - Autism Spectrum Disorder, ASD | Phase 2 | Completed | Joanne Kurtzberg, MD | 180 | 2016-09-01 | 2020-06-09 |
| Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism Computer Game - Autism | Phase 2 | Completed | Penn State University | 40 | 2016-08-01 | 2021-03-05 |
| Pilot Trial of Pregnenolone in Autism Pregnenolone, Placebo - Autism Spectrum Disorder, Autism | Phase 2 | Completed | Stanford University | 40 | 2016-01-29 | 2026-03-30 |
| A Study Evaluating the Effect of Vitamin D on Clinical Outcome in Autistic Children Vitamin D3, Placebo - Autism | Phase 2 | Completed | Ain Shams University | 42 | 2015-08-01 | 2016-07-12 |
| Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD) Auditory-Motor Mapping Training, Speech-Repetition Therapy - Autism | Phase 2 / Phase 3 | Completed | Beth Israel Deaconess Medical Center | 14 | 2014-11-01 | 2020-05-19 |
| Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism Umbilical cord mesenchymal stem cells - Autism | Phase 1 / Phase 2 | Completed | Translational Biosciences | 20 | 2014-07-01 | 2017-10-13 |
| Rapalogues for Autism Phenotype in TSC: A Feasibility Study Sirolimus, Everolimus - Tuberous Sclerosis Complex, Self-injury | Phase 2 | Completed | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 3 | 2013-07-01 | 2021-03-29 |
| Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine Memantine Hydrochloride (HCl), Placebo capsules - Autistic Disorder, Autism | Phase 2 | Completed | Forest Laboratories | 479 | 2012-09-01 | 2019-04-24 |
| Parent-delivered Massage for Children With Autism Parent massage tx group, Parent massage wait-list control group - Autism | Phase 2 / Phase 3 | Completed | Western Oregon University | 103 | 2012-09-01 | 2016-04-29 |
| Autologous Cord Blood Stem Cells for Autism Autologous Cord Blood Stem Cells, Placebo - Autism | Phase 2 | Completed | Sutter Health | 30 | 2012-08-01 | 2018-08-20 |
| Intranasal Oxytocin Treatment for Social Deficits in Children With Autism Oxytocin nasal spray, Placebo - Autism | Phase 2 | Completed | Stanford University | 54 | 2012-06-01 | 2019-07-15 |
| An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Memantine Hydrochloride (HCl) - Autism Spectrum Disorder (ASD), Autism | Phase 2 | Completed | Forest Laboratories | 906 | 2012-06-01 | 2014-08-07 |
| Open Label Clinical Trial of Vitamin D in Children With Autism Liquid Vitamin D - Autism, Vitamin D Deficiency | Phase 2 / Phase 3 | Completed | University of California, San Francisco | 10 | 2012-02-01 | 2019-10-09 |
Showing 20 of 53. Sign in to see all of them.
Autistic Disorder (53) · Autism Spectrum Disorder (17) · Asperger Syndrome (7) · Child Development Disorders, Pervasive (4) · Aggression (2) · Attention Deficit Disorder with Hyperactivity (2) · Obsessive-Compulsive Disorder (2) · Anxiety Disorders (1) · Anxiety, Separation (1) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Developmental Disabilities (1) · Food Hypersensitivity (1) · Fragile X Syndrome (1) · Generalized Anxiety Disorder (1)
Mental Disorders (53) · Neurodevelopmental Disorders (53) · Child Development Disorders, Pervasive (49) · Autism Spectrum Disorder (36) · Behavior (4) · Behavioral Symptoms (3) · Congenital Abnormalities (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Nervous System Diseases (3) · Aberrant Motor Behavior in Dementia (2) · Attention Deficit and Disruptive Behavior Disorders (2) · Heredodegenerative Disorders, Nervous System (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2)
Oxytocin (4) · Memantine (3) · Aripiprazole (2) · Risperidone (2) · 1-(quinoxalin-6-ylcarbonyl)piperidine (1) · Arginine Vasopressin (1) · Buspirone (1) · Carnitine (1) · Cholecalciferol (1) · Cholesterol (1) · Cognitive Behavioral Therapy (1) · Counseling (1) · Dextromethorphan (1) · Diet (1) · Diet Therapy (1)
Forest Laboratories (4) · Stanford University (3) · University of California, San Francisco (3) · Arizona State University (2) · Drexel University College of Medicine (2) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Joanne Kurtzberg, MD (2) · National Institute of Mental Health (NIMH) (2) · Sutter Health (2) · Yamo Pharmaceuticals LLC (2) · Ain Shams University (1) · Alexander Kolevzon (1) · Andrew Zimmerman (1) · Baylor College of Medicine (1) · Beth Israel Deaconess Medical Center (1)
United States (45) · Belgium (2) · Colombia (2) · Estonia (2) · France (2) · Hungary (2) · Iceland (2) · Italy (2) · New Zealand (2) · Poland (2) · Serbia (2) · South Africa (2) · South Korea (2) · Spain (2) · Ukraine (2)
James B. Adams, PhD (3) · Robert L Hendren, DO (3) · Ephraim Katz, PhD (2) · Jordan Lateiner, MS, MBA (2) · Michael Chez, MD (2) · Richard P Malone, MD (2) · Ana Carina Tamanaha, Student (1) · Andrew W. Zimmerman, M.D. (1) · Anett Kaale, PhD student (1) · Antonio Y Hardan, MD (1) · Antonio Y. Hardan, M.D. (1) · Antonio Y. Hardan, MD (1) · Beth Shaz, MD (1) · Carol A Parise, PhD (1)
PMID 37811711, PMID 36006807, PMID 18315448, PMID 20145986, PMID 20406576, PMID 20683766, PMID 21883204, PMID 22151477, PMID 23097920, PMID 23216716, PMID 23357440, PMID 23978163, PMID 24356715, PMID 24472253, PMID 25878901, PMID 28374207, PMID 28696286, PMID 30287612, PMID 36353577, PMID 37151032, PMID 38182792
P50HD055784 (1), P50MH100023 (1), R01HD091972 (1), R01MH072263 (1), R01MH073524 (1), R21MH080026 (1), R21NS043979 (1)